+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Brachytherapy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

  • PDF Icon

    Report

  • 119 Pages
  • November 2023
  • Region: Global
  • Acute Market Reports
  • ID: 5913024
Brachytherapy, a vital component of modern cancer treatment, offers a targeted approach to delivering radiation therapy, which is crucial in managing various types of cancer. The brachytherapy market is expected to grow at a CAGR of 7% during the forecast period of 2023 to 2031, driven by the demand for precise and targeted cancer treatment, the increasing incidence of cancer, and advancements in brachytherapy techniques. While the shortage of skilled professionals and infrastructure presents a restraint, efforts are ongoing to address these challenges. Market segmentation by dosage and product provides insights into specific areas of growth, and geographic trends highlight the importance of regional variations in demand. Competitive players are expected to continue their emphasis on innovation, partnerships, and product diversification to meet the evolving needs of cancer patients and healthcare providers.

Precise and Targeted Cancer Treatment

One of the primary drivers of the Brachytherapy market is its ability to deliver precise and targeted cancer treatment. Brachytherapy involves the placement of radioactive sources directly into or adjacent to the tumor site. This localized radiation therapy minimizes damage to healthy surrounding tissues while maximizing the radiation dose delivered to the tumor. The ability to spare healthy tissues and organs from radiation exposure significantly reduces the side effects of treatment and enhances patient outcomes.

Increasing Incidence of Cancer

The global increase in the incidence of cancer is a significant driver for the Brachytherapy market. Cancer is a leading cause of mortality worldwide, and the burden of cancer is expected to rise in the coming years. Brachytherapy plays a crucial role in the treatment of various cancers, including prostate cancer, cervical cancer, and breast cancer. The rising prevalence of cancer necessitates effective treatment modalities, making brachytherapy a key component in the fight against cancer.

Advancements in Brachytherapy Techniques

Advancements in brachytherapy techniques and technologies have driven the market's growth. Modern brachytherapy has evolved with innovations such as image-guided brachytherapy, 3D treatment planning, and adaptive radiation therapy. These technologies enable healthcare providers to plan and deliver brachytherapy with unprecedented precision and accuracy. Furthermore, the development of new brachytherapy products and treatment approaches has expanded the range of cancers that can be effectively treated with this modality.

Restraint in the Brachytherapy Market

A notable restraint in the Brachytherapy market is the limited availability of skilled professionals and infrastructure for brachytherapy. The successful implementation of brachytherapy requires a highly specialized team of radiation oncologists, medical physicists, and radiation therapists. Additionally, healthcare facilities need to invest in state-of-the-art equipment and infrastructure to perform brachytherapy procedures. The shortage of skilled professionals and the high upfront costs associated with establishing brachytherapy programs can limit its accessibility, particularly in resource-constrained regions.

Market Segmentation by Dosage (High-Dose Rate Brachytherapy, Low-Dose Rate Brachytherapy): High-Dose Rate (HDR) Brachytherapy Dominates the Market

The Brachytherapy market can be segmented by dosage into two categories: High-Dose Rate (HDR) Brachytherapy and Low-Dose Rate (LDR) Brachytherapy. In 2022, High-Dose Rate (HDR) Brachytherapy generated the highest revenue. The increased adoption of HDR brachytherapy is attributed to its shorter treatment duration and adaptability to various cancer types. For the period from 2023 to 2031, Low-Dose Rate (LDR) Brachytherapy is expected to exhibit the highest compound annual growth rate (CAGR). LDR brachytherapy is anticipated to find applications in prostate cancer and other tumor sites, making it a promising growth segment.

Market Segmentation by Product (Seeds, Applicators & Afterloaders, Electronic Brachytherapy): Seeds Dominate the Market

The Brachytherapy market can be segmented by product into three categories: seeds, applicators & afterloaders, and electronic brachytherapy. In 2022, seeds witnessed the highest revenue. Radioactive seeds are widely used in prostate cancer treatment and serve as an effective treatment modality. For the period from 2023 to 2031, electronic brachytherapy is expected to experience the highest CAGR. The demand for non-invasive and versatile electronic brachytherapy systems is projected to drive growth in this product segment.

North America Remains the Global Leader

The Brachytherapy market exhibits geographic variations in demand and growth. Geographic trends indicate that regions with a high burden of cancer, well-established healthcare infrastructure, and advancements in cancer care tend to lead in brachytherapy utilization. North America, with its advanced healthcare systems, has been a prominent market for brachytherapy. When considering the region with the highest CAGR during the forecast period from 2023 to 2031, Asia-Pacific is expected to exhibit substantial growth. The region's increasing cancer incidence, improving healthcare infrastructure, and efforts to enhance cancer care are driving the demand for brachytherapy. In terms of revenue percentage, North America is expected to maintain its position as the region with the highest revenue percentage throughout the forecast period. The region's investment in cancer research, access to advanced medical technologies, and increasing adoption of brachytherapy contribute to its prominence in the market.

Competitive Trends, Top Players, and Key Strategies

The Brachytherapy market features several key players, including Varian Medical Systems, Elekta AB, Eckert & Ziegler BEBIG, Becton, Dickinson & Company, Isoray Medical, Inc., iCAD, Inc., CIVCO Medical Solutions, Theragenics Corporation. These companies employ specific strategies to maintain and expand their market presence. In 2022, Varian Medical Systems held a significant market share, offering a comprehensive range of brachytherapy solutions and radiation therapy equipment. The company's strategy focused on product innovation and partnerships with healthcare institutions to expand their reach. Elekta AB, a global leader in radiotherapy solutions, excelled in providing advanced brachytherapy systems. Their strategy emphasized research and development, with a focus on introducing cutting-edge technologies and treatment planning software. Eckert & Ziegler BEBIG, a prominent player in brachytherapy products, positioned itself as a key player in the market. Their strategy centered on diversifying their product portfolio to cater to a broad range of brachytherapy applications. For the forecast period from 2023 to 2031, these companies are expected to continue their strategies, focusing on innovation, collaborations with healthcare providers, and expanding their product offerings to meet the evolving demands of the brachytherapy market.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofBrachytherapy market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Brachytherapy market and their expected impact during the forecast period
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Dosage Type

  • High-Dose Rate (HDR) Brachytherapy
  • Low-Dose Rate (LDR) Brachytherapy

Product

  • Seeds
  • Applicators & Afterloaders
  • Electronic Brachytherapy

Application

  • Prostate Cancer
  • Gynaecological Cancer
  • Breast Cancer
  • Others

Region Segment (2021 - 2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Brachytherapy market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Brachytherapy market?
  • Which is the largest regional market for Brachytherapy market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Brachytherapy market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Brachytherapy market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Brachytherapy Market
2.2. Global Brachytherapy Market, By Dosage Type, 2022 (US$ Million)
2.3. Global Brachytherapy Market, By Product, 2022 (US$ Million)
2.4. Global Brachytherapy Market, By Application, 2022 (US$ Million)
2.5. Global Brachytherapy Market, By Geography, 2022 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2022
3. Brachytherapy Market: Competitive Analysis
3.1. Market Positioning of Key Brachytherapy Market Vendors
3.2. Strategies Adopted by Brachytherapy Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031
4. Brachytherapy Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Brachytherapy Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter’s Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
5. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
5.3.1. High-Dose Rate (HDR) Brachytherapy
5.3.2. Low-Dose Rate (LDR) Brachytherapy
6. Brachytherapy Market: By Product, 2021-2031, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
6.3.1. Seeds
6.3.2. Applicators & Afterloaders
6.3.3. Electronic Brachytherapy
7. Brachytherapy Market: By Application, 2021-2031, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2022 Versus 2031
7.3. Market Segmentation
7.3.1. Prostate Cancer
7.3.2. Gynaecological Cancer
7.3.3. Breast Cancer
7.3.4. Others
8. North America Brachytherapy Market, 2021-2031, USD (Million)
8.1. Market Overview
8.2. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
8.3. Brachytherapy Market: By Product, 2021-2031, USD (Million)
8.4. Brachytherapy Market: By Application, 2021-2031, USD (Million)
8.5. Brachytherapy Market: By Region, 2021-2031, USD (Million)
8.5.1. North America
8.5.1.1. U.S.
8.5.1.1.1. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
8.5.1.1.2. Brachytherapy Market: By Product, 2021-2031, USD (Million)
8.5.1.1.3. Brachytherapy Market: By Application, 2021-2031, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
8.5.1.2.2. Brachytherapy Market: By Product, 2021-2031, USD (Million)
8.5.1.2.3. Brachytherapy Market: By Application, 2021-2031, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
8.5.1.3.2. Brachytherapy Market: By Product, 2021-2031, USD (Million)
8.5.1.3.3. Brachytherapy Market: By Application, 2021-2031, USD (Million)
9. UK and European Union Brachytherapy Market, 2021-2031, USD (Million)
9.1. Market Overview
9.2. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
9.3. Brachytherapy Market: By Product, 2021-2031, USD (Million)
9.4. Brachytherapy Market: By Application, 2021-2031, USD (Million)
9.5. Brachytherapy Market: By Region, 2021-2031, USD (Million)
9.5.1. UK and European Union
9.5.1.1. UK
9.5.1.1.1. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
9.5.1.1.2. Brachytherapy Market: By Product, 2021-2031, USD (Million)
9.5.1.1.3. Brachytherapy Market: By Application, 2021-2031, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
9.5.1.2.2. Brachytherapy Market: By Product, 2021-2031, USD (Million)
9.5.1.2.3. Brachytherapy Market: By Application, 2021-2031, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
9.5.1.3.2. Brachytherapy Market: By Product, 2021-2031, USD (Million)
9.5.1.3.3. Brachytherapy Market: By Application, 2021-2031, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
9.5.1.4.2. Brachytherapy Market: By Product, 2021-2031, USD (Million)
9.5.1.4.3. Brachytherapy Market: By Application, 2021-2031, USD (Million)
9.5.1.5. France
9.5.1.5.1. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
9.5.1.5.2. Brachytherapy Market: By Product, 2021-2031, USD (Million)
9.5.1.5.3. Brachytherapy Market: By Application, 2021-2031, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
9.5.1.6.2. Brachytherapy Market: By Product, 2021-2031, USD (Million)
9.5.1.6.3. Brachytherapy Market: By Application, 2021-2031, USD (Million)
10. Asia Pacific Brachytherapy Market, 2021-2031, USD (Million)
10.1. Market Overview
10.2. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
10.3. Brachytherapy Market: By Product, 2021-2031, USD (Million)
10.4. Brachytherapy Market: By Application, 2021-2031, USD (Million)
10.5. Brachytherapy Market: By Region, 2021-2031, USD (Million)
10.5.1. Asia Pacific
10.5.1.1. China
10.5.1.1.1. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
10.5.1.1.2. Brachytherapy Market: By Product, 2021-2031, USD (Million)
10.5.1.1.3. Brachytherapy Market: By Application, 2021-2031, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
10.5.1.2.2. Brachytherapy Market: By Product, 2021-2031, USD (Million)
10.5.1.2.3. Brachytherapy Market: By Application, 2021-2031, USD (Million)
10.5.1.3. India
10.5.1.3.1. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
10.5.1.3.2. Brachytherapy Market: By Product, 2021-2031, USD (Million)
10.5.1.3.3. Brachytherapy Market: By Application, 2021-2031, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
10.5.1.4.2. Brachytherapy Market: By Product, 2021-2031, USD (Million)
10.5.1.4.3. Brachytherapy Market: By Application, 2021-2031, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
10.5.1.5.2. Brachytherapy Market: By Product, 2021-2031, USD (Million)
10.5.1.5.3. Brachytherapy Market: By Application, 2021-2031, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
10.5.1.6.2. Brachytherapy Market: By Product, 2021-2031, USD (Million)
10.5.1.6.3. Brachytherapy Market: By Application, 2021-2031, USD (Million)
11. Latin America Brachytherapy Market, 2021-2031, USD (Million)
11.1. Market Overview
11.2. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
11.3. Brachytherapy Market: By Product, 2021-2031, USD (Million)
11.4. Brachytherapy Market: By Application, 2021-2031, USD (Million)
11.5. Brachytherapy Market: By Region, 2021-2031, USD (Million)
11.5.1. Latin America
11.5.1.1. Brazil
11.5.1.1.1. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
11.5.1.1.2. Brachytherapy Market: By Product, 2021-2031, USD (Million)
11.5.1.1.3. Brachytherapy Market: By Application, 2021-2031, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
11.5.1.2.2. Brachytherapy Market: By Product, 2021-2031, USD (Million)
11.5.1.2.3. Brachytherapy Market: By Application, 2021-2031, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
11.5.1.3.2. Brachytherapy Market: By Product, 2021-2031, USD (Million)
11.5.1.3.3. Brachytherapy Market: By Application, 2021-2031, USD (Million)
12. Middle East and Africa Brachytherapy Market, 2021-2031, USD (Million)
12.1. Market Overview
12.2. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
12.3. Brachytherapy Market: By Product, 2021-2031, USD (Million)
12.4. Brachytherapy Market: By Application, 2021-2031, USD (Million)
12.5. Brachytherapy Market: By Region, 2021-2031, USD (Million)
12.5.1. Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
12.5.1.1.2. Brachytherapy Market: By Product, 2021-2031, USD (Million)
12.5.1.1.3. Brachytherapy Market: By Application, 2021-2031, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
12.5.1.2.2. Brachytherapy Market: By Product, 2021-2031, USD (Million)
12.5.1.2.3. Brachytherapy Market: By Application, 2021-2031, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Brachytherapy Market: By Dosage Type, 2021-2031, USD (Million)
12.5.1.3.2. Brachytherapy Market: By Product, 2021-2031, USD (Million)
12.5.1.3.3. Brachytherapy Market: By Application, 2021-2031, USD (Million)
13. Company Profile
13.1. Varian Medical Systems
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. Elekta AB
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. Eckert & Ziegler BEBIG
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. Becton
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. Dickinson & Company
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. Isoray Medical, Inc.
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. iCAD, Inc.
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. CIVCO Medical Solutions
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. Theragenics Corporation
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. Other Notable Players
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives
List of Figures
Fig. 1 Global Brachytherapy Market: Market Coverage
Fig. 2 Research Methodology and Data Sources
Fig. 3 Market Size Estimation-Top Down & Bottom-Up Approach
Fig. 4 Global Brachytherapy Market: Quality Assurance
Fig. 5 Global Brachytherapy Market, By Dosage Type, 2022
Fig. 6 Global Brachytherapy Market, By Product, 2022
Fig. 7 Global Brachytherapy Market, By Application, 2022
Fig. 8 Global Brachytherapy Market, By Geography, 2022
Fig. 9 Market Geographical Opportunity Matrix-Global Brachytherapy Market, 2022
Fig. 10 Market Positioning of Key Brachytherapy Market Players, 2022
Fig. 11 Global Brachytherapy Market-Tier Analysis-Percentage of Revenues by Tier Level, 2022 Versus 2031
Fig. 12 Global Brachytherapy Market, By Dosage Type, 2022 Vs 2031, %
Fig. 13 Global Brachytherapy Market, By Product, 2022 Vs 2031, %
Fig. 14 Global Brachytherapy Market, By Application, 2022 Vs 2031, %
Fig. 15 U.S. Brachytherapy Market (US$ Million), 2021-2031
Fig. 16 Canada Brachytherapy Market (US$ Million), 2021-2031
Fig. 17 Rest of North America Brachytherapy Market (US$ Million), 2021-2031
Fig. 18 UK Brachytherapy Market (US$ Million), 2021-2031
Fig. 19 Germany Brachytherapy Market (US$ Million), 2021-2031
Fig. 20 Spain Brachytherapy Market (US$ Million), 2021-2031
Fig. 21 Italy Brachytherapy Market (US$ Million), 2021-2031
Fig. 22 France Brachytherapy Market (US$ Million), 2021-2031
Fig. 23 Rest of Europe Brachytherapy Market (US$ Million), 2021-2031
Fig. 24 China Brachytherapy Market (US$ Million), 2021-2031
Fig. 25 Japan Brachytherapy Market (US$ Million), 2021-2031
Fig. 26 India Brachytherapy Market (US$ Million), 2021-2031
Fig. 27 Australia Brachytherapy Market (US$ Million), 2021-2031
Fig. 28 South Korea Brachytherapy Market (US$ Million), 2021-2031
Fig. 29 Rest of Asia Brachytherapy Market (US$ Million), 2021-2031
Fig. 30 Brazil Brachytherapy Market (US$ Million), 2021-2031
Fig. 31 Mexico Brachytherapy Market (US$ Million), 2021-2031
Fig. 32 Rest of Latin America Brachytherapy Market (US$ Million), 2021-2031
Fig. 33 GCC Brachytherapy Market (US$ Million), 2021-2031
Fig. 34 Africa Brachytherapy Market (US$ Million), 2021-2031
Fig. 35 Rest of Middle East and Africa Brachytherapy Market (US$ Million), 2021-2031
List of Tables
Table 1 Global Brachytherapy Market By Dosage Type, 2021-2031, USD (Million)
Table 2 Global Brachytherapy Market By Product, 2021-2031, USD (Million)
Table 3 Global Brachytherapy Market By Application, 2021-2031, USD (Million)
Table 4 North America Brachytherapy Market By Dosage Type, 2021-2031, USD (Million)
Table 5 North America Brachytherapy Market By Product, 2021-2031, USD (Million)
Table 6 North America Brachytherapy Market By Application, 2021-2031, USD (Million)
Table 7 U.S. Brachytherapy Market By Dosage Type, 2021-2031, USD (Million)
Table 8 U.S. Brachytherapy Market By Product, 2021-2031, USD (Million)
Table 9 U.S. Brachytherapy Market By Application, 2021-2031, USD (Million)
Table 10 Canada Brachytherapy Market By Dosage Type, 2021-2031, USD (Million)
Table 11 Canada Brachytherapy Market By Product, 2021-2031, USD (Million)
Table 12 Canada Brachytherapy Market By Application, 2021-2031, USD (Million)
Table 13 Rest of North America Brachytherapy Market By Dosage Type, 2021-2031, USD (Million)
Table 14 Rest of North America Brachytherapy Market By Product, 2021-2031, USD (Million)
Table 15 Rest of North America Brachytherapy Market By Application, 2021-2031, USD (Million)
Table 16 UK and European Union Brachytherapy Market By Dosage Type, 2021-2031, USD (Million)
Table 17 UK and European Union Brachytherapy Market By Product, 2021-2031, USD (Million)
Table 18 UK and European Union Brachytherapy Market By Application, 2021-2031, USD (Million)
Table 19 UK Brachytherapy Market By Dosage Type, 2021-2031, USD (Million)
Table 20 UK Brachytherapy Market By Product, 2021-2031, USD (Million)
Table 21 UK Brachytherapy Market By Application, 2021-2031, USD (Million)
Table 22 Germany Brachytherapy Market By Dosage Type, 2021-2031, USD (Million)
Table 23 Germany Brachytherapy Market By Product, 2021-2031, USD (Million)
Table 24 Germany Brachytherapy Market By Application, 2021-2031, USD (Million)
Table 25 Spain Brachytherapy Market By Dosage Type, 2021-2031, USD (Million)
Table 26 Spain Brachytherapy Market By Product, 2021-2031, USD (Million)
Table 27 Spain Brachytherapy Market By Application, 2021-2031, USD (Million)
Table 28 Italy Brachytherapy Market By Dosage Type, 2021-2031, USD (Million)
Table 29 Italy Brachytherapy Market By Product, 2021-2031, USD (Million)
Table 30 Italy Brachytherapy Market By Application, 2021-2031, USD (Million)
Table 31 France Brachytherapy Market By Dosage Type, 2021-2031, USD (Million)
Table 32 France Brachytherapy Market By Product, 2021-2031, USD (Million)
Table 33 France Brachytherapy Market By Application, 2021-2031, USD (Million)
Table 34 Rest of Europe Brachytherapy Market By Dosage Type, 2021-2031, USD (Million)
Table 35 Rest of Europe Brachytherapy Market By Product, 2021-2031, USD (Million)
Table 36 Rest of Europe Brachytherapy Market By Application, 2021-2031, USD (Million)
Table 37 Asia Brachytherapy Market By Dosage Type, 2021-2031, USD (Million)
Table 38 Asia Brachytherapy Market By Product, 2021-2031, USD (Million)
Table 39 Asia Brachytherapy Market By Application, 2021-2031, USD (Million)
Table 40 China Brachytherapy Market By Dosage Type, 2021-2031, USD (Million)
Table 41 China Brachytherapy Market By Product, 2021-2031, USD (Million)
Table 42 China Brachytherapy Market By Application, 2021-2031, USD (Million)
Table 43 Japan Brachytherapy Market By Dosage Type, 2021-2031, USD (Million)
Table 44 Japan Brachytherapy Market By Product, 2021-2031, USD (Million)
Table 45 Japan Brachytherapy Market By Application, 2021-2031, USD (Million)
Table 46 India Brachytherapy Market By Dosage Type, 2021-2031, USD (Million)
Table 47 India Brachytherapy Market By Product, 2021-2031, USD (Million)
Table 48 India Brachytherapy Market By Application, 2021-2031, USD (Million)
Table 49 Australia Brachytherapy Market By Dosage Type, 2021-2031, USD (Million)
Table 50 Australia Brachytherapy Market By Product, 2021-2031, USD (Million)
Table 51 Australia Brachytherapy Market By Application, 2021-2031, USD (Million)
Table 52 South Korea Brachytherapy Market By Dosage Type, 2021-2031, USD (Million)
Table 53 South Korea Brachytherapy Market By Product, 2021-2031, USD (Million)
Table 54 South Korea Brachytherapy Market By Application, 2021-2031, USD (Million)
Table 55 Latin America Brachytherapy Market By Dosage Type, 2021-2031, USD (Million)
Table 56 Latin America Brachytherapy Market By Product, 2021-2031, USD (Million)
Table 57 Latin America Brachytherapy Market By Application, 2021-2031, USD (Million)
Table 58 Brazil Brachytherapy Market By Dosage Type, 2021-2031, USD (Million)
Table 59 Brazil Brachytherapy Market By Product, 2021-2031, USD (Million)
Table 60 Brazil Brachytherapy Market By Application, 2021-2031, USD (Million)
Table 61 Mexico Brachytherapy Market By Dosage Type, 2021-2031, USD (Million)
Table 62 Mexico Brachytherapy Market By Product, 2021-2031, USD (Million)
Table 63 Mexico Brachytherapy Market By Application, 2021-2031, USD (Million)
Table 64 Rest of Latin America Brachytherapy Market By Dosage Type, 2021-2031, USD (Million)
Table 65 Rest of Latin America Brachytherapy Market By Product, 2021-2031, USD (Million)
Table 66 Rest of Latin America Brachytherapy Market By Application, 2021-2031, USD (Million)
Table 67 Middle East and Africa Brachytherapy Market By Dosage Type, 2021-2031, USD (Million)
Table 68 Middle East and Africa Brachytherapy Market By Product, 2021-2031, USD (Million)
Table 69 Middle East and Africa Brachytherapy Market By Application, 2021-2031, USD (Million)
Table 70 GCC Brachytherapy Market By Dosage Type, 2021-2031, USD (Million)
Table 71 GCC Brachytherapy Market By Product, 2021-2031, USD (Million)
Table 72 GCC Brachytherapy Market By Application, 2021-2031, USD (Million)
Table 73 Africa Brachytherapy Market By Dosage Type, 2021-2031, USD (Million)
Table 74 Africa Brachytherapy Market By Product, 2021-2031, USD (Million)
Table 75 Africa Brachytherapy Market By Application, 2021-2031, USD (Million)
Table 76 Rest of Middle East and Africa Brachytherapy Market By Dosage Type, 2021-2031, USD (Million)
Table 77 Rest of Middle East and Africa Brachytherapy Market By Product, 2021-2031, USD (Million)
Table 78 Rest of Middle East and Africa Brachytherapy Market By Application, 2021-2031, USD (Million)

Companies Mentioned

  • Varian Medical Systems
  • Elekta AB
  • Eckert & Ziegler BEBIG
  • Becton
  • Dickinson & Company
  • Isoray Medical, Inc.
  • iCAD, Inc.
  • CIVCO Medical Solutions
  • Theragenics Corporation